This Material Change Report just relates to the filing of the finalized Hepalink/Eastern deal. Here is the summary:

"Resverlogix closed the previously-announced private placement of 18,870,000 units, each unit (“Unit”) being comprised of one (1) common share and 0.075358 common share purchase warrants, for aggregate proceeds of approximately CAD$50 million, or CAD$2.67 per Unit. Each whole warrant is exercisable into one common share at CAD$2.67 per share for a period of five years."